Table 4.
All DHC with outcome data (n = 61) | Favorable outcome (n = 10) | Unfavorable outcome (n = 51) | p value | |
---|---|---|---|---|
Demographics | ||||
Age—years; mean ± SD | 50.6 ± 10.9 | 43.3 ± 11.9 | 51.8 ± 10.1 | 0.024 |
Sex–female/male | 45 (73.8)/16 (26.2) | 8 (72.7)/2 (18.2) | 37 (77.1)/14 (29.2) | 0.624 |
ICP crisis | ||||
Lag ICP crisis (days) (IQR) | 2.0 (3.0) | 1.0 (3.0) | 2.0 (5.0) | 0.501 |
Lag DHC (days) (IQR) | 2.0 (4.0) | 3.0 (3.0) | 2.0 (5.0) | 0.836 |
Primary/secondary DHC | 8 (13.1)/53 (86.9) | 2 (20.0)/8 (80.0) | 6 (11.8)/45 (88.2) | 0.481 |
Aneurysm location; no. (%) | 0.524 | |||
Ant. circulation | 59 (96.7) | 10 (100.0) | 49 (96.1) | |
Post. circulation | 2 (3.3) | 0 (0.0) | 2 (3.9) | |
Aneurysm size Max. diameter (mm)—mean ± SD |
7.0 ± 5.0 | 7.5 ± 9.0 | 7.0 ± 5.0 | 0.506 |
Hemorrhage severity | ||||
Hunt and Hess grade; no. (%) | 0.908 | |||
Grade 1 | 3 (4.9) | 0 (0.0) | 3 (5.9) | |
Grade 2 | 9 (14.8) | 2 (20.0) | 7 (13.7) | |
Grade 3 | 14 (23.0) | 2 (20.0) | 12 (23.5) | |
Grade 4 | 21 (34.4) | 4 (40.0) | 17 (33.3) | |
Grade 5 | 14 (23.0) | 2 (20.0) | 12 (23.5) | |
Modified Fisher scale; no. (%) | 0.433 | |||
Grade 1 | 6 (98.4) | 2 (20.0) | 4 (7.8) | |
Grade 2 | 36 (59.0) | 1 (10.0) | 2 (3.9) | |
Grade 3 | 22 (36.1) | 2 (20.0) | 20 (39.2) | |
Grade 4 | 30 (49.2) | 5 (50.0) | 25 (49.0) | |
Aneurysm occlusion; no. (%) | 0.140 | |||
Clipping/endovascular | 28 (45.9)/23 (37.7) | 8 (80.0)/2 (20.0) | 28 (54.9)/23 (45.1) | |
DCI treatment; no. (%) | ||||
DCI | 44 (72.1) | 7 (70.0) | 37 (72.5) | 0.869 |
ERT | 25 (41.0) | 4 (40.0) | 21 (41.2) | 0.945 |
Spasmolysis | 22 (36.1) | 3 (30.0) | 19 (37.3) | 0.262 |
CLINA | 7 (11.5) | 2 (20.0) | 5 (9.8) | 0.355 |
Clinical outcome; no. (%) | ||||
DCI-related infarction | 28 (45.9) | 3 (30.0) | 25 (49.0) | 0.270 |
Cranioplasty | 34 (55.7) | 10 (100.0) | 24 (47.1) | |
Lag (days) | 85.0 (84.0) | 93.5 (84.0) | 70.0 (63.0) | 0.512 |
Early (≤ 90)/late (> 90) | 13 (21.3)/21 (34.4) | 5 (50.0)/5 (50.0) | 8 (33.3)/16 (31.4) |
CLINA continuous local intra-arterial nimodipine applications; DHC decompressive hemicraniectomy; ERT endovascular rescue treatment; ICP intracranial pressure; IQR interquartile range; SD standard deviations